TAP Biosystems is a leading global provider of automated cell culture and fermentation systems to the bio-pharma, regenerative medicine and industrial biotechnology sectors, focusing on:
• Bioprocess development
• Cell therapy & stem cell research
• GMP manufacture of biologics
• Discovery research TAP Biosystems is now part of the Sartorius Stedim Biotech Group. The acquisition will enable Sartorius to further extend its bioprocess portfolio in the area of fermentation, especially in the early phases of product and process development.